1 Min Read
July 24 (Reuters) - Spectral Medical Inc:
* FDA accepts Spectral’s PMA for toraymyxin for review
* Says will continue to work closely with FDA to facilitate a timely process Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.